MYL-1701P-3001

· Mylan Pharmaceuticals Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MYL-1701P-3001, covering 2022-08-26 to 2022-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study of MYL-1701P-3001 for Safety and Efficacy [Phase 3]